Delivering Novel Therapies for RAS/MAPK Pathway Driven Cancersđź”’ SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for verastem.com. This domain is officially recognized as Verastem Oncology. According to their official web presence, their primary focus is: "Embracing the power of partnership and collaboration to develop novel cancer therapies.".
Table of Contents
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 80Outbound Links: 2
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$564
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- verastem.comAvailable
- verastem.netAvailable
- verastem.orgAvailable
- verastem.ioAvailable
- verastem.coAvailable
- verastem.aiTaken
Official Contact & Profiles
Socials:x.comlinkedin.com
Content Snippets from verastem.com
"Approximately 30% of patients with low-grade serous ovarian cancer have a KRAS mutation, making it the most common type of gene mutation in the disease. We are advancing innovation in rare ovarian cancer, including the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer."
"KRAS G12D represents 26% of all KRAS mutations, making it the most prevalent KRAS mutation in human cancers."
"Advancing therapies that directly target KRAS G12D may help address a significant unmet need across multiple solid tumor types."
"Our pipeline is powered by ongoing trials and strategic collaborations centered on novel small molecule inhibitors targeting the critical RAS/MAPK signaling pathway known to drive cell survival and tumor growth. This includes targeting RAS directly with KRAS G12D inhibition, targeting the pathway downstream with RAF/MEK inhibition, and targeting the parallel pathway that drives resistance with FAK inhibition."
Key Topics & Focus Areas for verastem.com:
Delivering the first breakthrough in a rare ovarian cancer
Selectively targeting the most prevalent KRAS mutation in human cancers
Precision targeting of RAS/MAPK pathway-driven cancers
Get our latest news and updates
Ready to make an impact?
By comparing verastem.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to verastem.com.
Frequently Asked Questions
Is verastem.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of verastem.com?
As of July 24, 2026, verastem.com holds an estimated domain authority score of 31/100 based on our VisitRank tracking algorithms.
What are the top alternatives to verastem.com?
You can find the best alternatives and similar sites to verastem.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for verastem.com:
vreastem.comveastem.comveerastem.comvarastem.comverestem.comverastam.comvwrastem.comvsrastem.com